Showing results (31-40 of 60) with videos related to
Sort By:
Pageof 6
Journal of Epidemiology and Global Health|January 23, 2024
A Quasi-experimental Study on the Effect of Pre-entry Tuberculosis Screening for Immigrants on Treatment Outcomes in South Korea: A Difference-in-Differences AnalysisSarah Yu, Dawoon Jeong, Hee-Yeon Kang, et al.Tuberculosis and Respiratory Diseases|February 19, 2026
Post-Tuberculosis Health: A Holistic Perspective on Multisystem Sequelae and Long-Term WellbeingJinsoo Min, Yoolwon Jeong, Hyung Woo Kim, et al.Plos One|June 16, 2022
Risk factors associated with tuberculosis recurrence in South Korea determined using a nationwide cohort studyHin Moi Youn, Moon-Kyung Shin, Dawoon Jeong, et al.Journal of Infection and Public Health|March 7, 2025
Disagreement on estimating cause of death under tuberculosis treatment between the national tuberculosis registry and statistics data in South Korea, 2011-2020Chiwook Chung, Seung Won Lee, Dawoon Jeong, et al.DNA Research : an International Journal for Rapid Publication of Reports on Genes and Genomes|August 10, 2024
Pan-lineage Mycobacterium tuberculosis reference genome for enhanced molecular diagnosisKunhyung Bahk, Joohon Sung, Mitsuko Seki, et al.Journal of Preventive Medicine and Public Health = Yebang Uihakhoe Chi|June 9, 2022
Cohort Profile: Korean Tuberculosis and Post-Tuberculosis Cohort Constructed by Linking the Korean National Tuberculosis Surveillance System and National Health Information DatabaseDawoon Jeong, Hee-Yeon Kang, Jinsun Kim, et al.ERJ Open Research|November 12, 2025
The impact of population ageing on tuberculosis incidence, mortality, and case fatality in South Korea: a nationwide retrospective studySeung Won Lee, Doosoo Jeon, Hongjo Choi, et al.Plos Medicine|July 14, 2021
Evaluating the impact of the nationwide public-private mix (PPM) program for tuberculosis under National Health Insurance in South Korea: A difference in differences analysisSarah Yu, Hojoon Sohn, Hae-Young Kim, et al.Journal of Korean Medical Science|February 7, 2023
Nationwide Treatment Outcomes of Patients With Multidrug/Rifampin-Resistant Tuberculosis in Korea, 2011-2017: A Retrospective Cohort Study (Korean TB-POST)Hongjo Choi, Jeongha Mok, Young Ae Kang, et al.Yonsei Medical Journal|January 1, 2025
Comparison of Patients Who Were Not Evaluated and Lost to Follow-Up with Multidrug/Rifampin-Resistant Tuberculosis in South KoreaHongjo Choi, Jeongha Mok, Young Ae Kang, et al.Pageof 6